Trial Site Detail
Drug: |
Imatinib |
|||
|---|---|---|---|---|
Trial: |
A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing c-Kit Gene (Extension of US Phase II study, B2222) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Helsinki University Central Hospital |
Principal Investigator: |
Heikki Joensuu, MD |
|---|---|
Contact: |
ia Viskari, +358-9-4711, mia.viskari@hus.fi |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Helsinki University Central Hospital Website: |
http://www.hus.fi/default.asp?path=59 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.